Session # C-84

Multi-gene Panel Testing for Prostate Cancer: What Have We Learned So Far?

• Hereditary prostate cancer testing is underutilized especially when compared to hereditary breast cancer testing
• HOXB13 was a new finding, identified in 17% of positive patients
• 13% of positive patients did not meet NCCN genetic testing guidelines for BRCA1/2

• Authors: Michelle Jackson; Carin Espenschied; Lauren Bowling; Holly LaDuca
• Conference: NSGC 2017
• Date: Friday, Sep 15, 2017 1:15pm - 2:30pm